Angiotensin II-stimulated vascular endothelial growth factor expression in bovine retinal pericytes.
暂无分享,去创建一个
K. Suzuma | H. Takagi | Y. Honda | A. Otani | H. Oh | E. Ikeda | Y Honda | A Otani | H Takagi | H Oh | K Suzuma | M Matsumura | E Ikeda | M. Matsumura | M. Matsumura | Yoshihito Honda
[1] L. Aiello,et al. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. , 1996, Investigative ophthalmology & visual science.
[2] M. Daemen,et al. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. , 1991, Circulation research.
[3] T. Shono,et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.
[4] G. Breier,et al. Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.
[5] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[6] A. Sjølie,et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes , 1998, The Lancet.
[7] H. Chase,et al. Angiotensin-converting enzyme inhibitor therapy and diabetic retinopathy. , 1992, Annals of ophthalmology.
[8] G. King,et al. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes , 1988, The Journal of experimental medicine.
[9] V. Dzau,et al. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. , 1989, The Journal of clinical investigation.
[10] R. Hamdy,et al. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells. , 1998, Biochimica et biophysica acta.
[11] A. Pardee,et al. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.
[12] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[13] J. Gitlin,et al. Culture of retinal capillary cells using selective growth media. , 1983, Microvascular research.
[14] B. Franza,et al. Fos and jun: The AP-1 connection , 1988, Cell.
[15] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[16] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[17] P T de Jong,et al. Angiotensin levels in the eye. , 1994, Investigative ophthalmology & visual science.
[18] S. Whitebread,et al. Preliminary biochemical characterization of two angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.
[19] P T de Jong,et al. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. , 1989, The Journal of clinical endocrinology and metabolism.
[20] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[21] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[22] N. Morel,et al. Pericyte physiology , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[24] Roche ResearchCenter,et al. Vascular Permeability Factor: A Tumor-derived Polypeptide that Induces Endothelial Cell and Monocyte Procoagulant Activity, and Promotes Monocyte Migration , 1990 .
[25] H. Dvorak,et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.
[26] P A D'Amore,et al. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.
[27] T. Quinn,et al. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[28] P. Delafontaine,et al. Angiotensin II regulates insulin-like growth factor I gene expression in vascular smooth muscle cells. , 1993, The Journal of biological chemistry.
[29] P. Timmermans,et al. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). , 1990, The Journal of pharmacology and experimental therapeutics.
[30] S. Feman,et al. Serum angiotensin converting enzyme in diabetic patients. , 1993, The American journal of the medical sciences.
[31] C. Kahn,et al. Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. , 1985, The Journal of clinical investigation.
[32] T. Curran,et al. Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[33] Joan W. Miller,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[34] H. Itoh,et al. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. , 1993, The Journal of clinical investigation.
[35] Shay Soker,et al. Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.
[36] R. Morishita,et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[37] R. Klein,et al. The incidence of vision loss in a diabetic population. , 1988, Ophthalmology.
[38] A. Ullrich,et al. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis , 1993, Cell.
[39] 今井 泰平. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells , 1993 .
[40] M. P. Carson,et al. Junctional transfer of small molecules in cultured bovine brain microvascular endothelial cells and pericytes. , 1987, Microvascular research.
[41] J. Fiddes,et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. , 1991, The Journal of biological chemistry.
[42] M. Paul,et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. , 1995, The Journal of clinical investigation.
[43] H. Parving. Impact of Blood Pressure and Antihypertensive Treatment on Incipient and Overt Nephropathy, Retinopathy, and Endothelial Permeability in Diabetes Mellitus , 1991, Diabetes Care.
[44] Y. Kim,et al. Vascular endothelial growth factor mRNA in pericytes is upregulated by phorbol myristate acetate. , 1998, Hypertension.
[45] HitoshiTakagi,et al. Angiotensin II Potentiates Vascular Endothelial Growth Factor–Induced Angiogenic Activity in Retinal Microcapillary Endothelial Cells , 1998 .
[46] H Ueno,et al. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. , 1992, Science.
[47] H. Dvorak,et al. Tumor-secreted vascular permeability factor increases cytosolic Ca2+ and von Willebrand factor release in human endothelial cells. , 1991, The American journal of pathology.
[48] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[49] P. Timmermans,et al. Angiotensin II receptors and angiotensin II receptor antagonists. , 1993, Pharmacological reviews.
[50] C. Patterson,et al. Induction of Vascular Endothelial Growth Factor Gene Expression by Interleukin-1 in Rat Aortic Smooth Muscle Cells (*) , 1995, The Journal of Biological Chemistry.
[51] V. Dzau. Molecular biology of angiotensin II biosynthesis and receptors. , 1995, The Canadian journal of cardiology.
[52] L. Aiello,et al. Comparative Analysis of Vascular Endothelial Growth Factor Receptors on Retinal and Aortic Vascular Endothelial Cells , 1995, Diabetes.
[53] T. Hunter,et al. Oncogene jun encodes a sequence-specific trans- activator similar to AP-1 , 1988, Nature.
[54] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.